AMENDMENT NO. 3 dated as of February 22, 2021 to CREDIT AGREEMENT Dated as of December 23, 2016Credit Agreement • February 23rd, 2021 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • New York
THIS AMENDMENT NO. 3 (“Amendment”), dated as of February 22, 2021 (the “Effective Date”), is entered into by and among MYRIAD GENETICS, INC., a Delaware corporation (the “Borrower”), the Lenders party hereto, and JPMORGAN CHASE BANK, N.A., as Administrative Agent (the “Administrative Agent”). Each capitalized term used herein and not defined herein shall have the meaning ascribed thereto in the Credit Agreement, dated as of December 23, 2016 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”), by and among the Borrower, the Lenders from time to time party thereto, and the Administrative Agent.
